Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,894 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07131735 | Intraoperative Detection of Breast Cancer by Electrosurgical Gas Analysis and Artificial Intelligence | recruiting | — | 30 | Pontificia Universidad Catolica de ChileOTHER | 1 | Aug 20, 2025 | clinicaltrials |
| NCT07133087 | Body Awareness, Upper Extremity Function, and Quality of Life in Breast Cancer Survivors | recruiting | — | 42 | Halic UniversityOTHER | 1 | Aug 20, 2025 |
| NCT05744687 | Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer | recruiting | Phase 2 / Phase 3 | 374 | Shanghai Pharmaceuticals Holding Co., LtdINDUSTRY | 1 | Aug 17, 2025 | clinicaltrials |
| NCT07071402 | A Study on the Treatment of Early Small Breast Cancer With Ultrasound-guided Vacuum-assisted Excision Combined With Surgery | recruiting | N/A | 120 | Xijing HospitalOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT06590727 | Psychological Well-being in Patients With Breast Cancer(RAISE) | recruiting | — | 2,400 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 14, 2025 | clinicaltrials |
| NCT07008976 | Clinical Trial of TQB2102 for Injection Versus Trastuzumab Emtansine for Injection in HER2-positive Advanced Breast Cancer | recruiting | Phase 3 | 246 | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 14, 2025 | clinicaltrials |
| NCT06830590 | Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population(BrCa) | recruiting | — | 300 | Liaquat University of Medical & Health SciencesOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT06371274 | A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC. | recruiting | N/A | 29 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT06611813 | Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01) | recruiting | Phase 2 | 30 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT06874933 | Neoadjuvant Chemotherapy in Combination With Anlotinib and Benmelstobart for HR+/HER2- Breast Cancer (NEOTORCH-BREAST03) | recruiting | Phase 2 | 35 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Aug 12, 2025 | clinicaltrials |
| NCT03740893 | PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer(PHOENIX) | recruiting | Phase 2 | 119 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT06700070 | A Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors | recruiting | Early Phase 1 | 12 | Pure Biologics S.A.INDUSTRY | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07113613 | Prospective Study on Exemption of Tumor Bed Boost Radiotherapy for pCR Patients After Breast Conserving Surgery With Neoadjuvant Therapy | recruiting | Phase 2 | 150 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07108309 | BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast Cancer(AREAL) | recruiting | Phase 2 | 124 | BiocadINDUSTRY | 2 | Aug 7, 2025 | clinicaltrials |
| NCT07108517 | A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth(IC-Growth) | recruiting | N/A | 180 | Centre for Research and Technology HellasOTHER | 1 | Aug 7, 2025 | clinicaltrials |
| NCT06002022 | Evaluation of Improvements in Patient-reported Quality of Life(REBECCA-QoL) | recruiting | N/A | 110 | Fundación para la Investigación del Hospital Clínico de ValenciaOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07106112 | Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant Therapy(COMET) | recruiting | N/A | 110 | Saint Petersburg State University, RussiaOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07104266 | Triple Negative Breast Cancer and Celecoxib. Pilot Study | recruiting | Phase 2 | 30 | Université de SherbrookeOTHER | 1 | Aug 5, 2025 | clinicaltrials |
| NCT07101601 | Study of DM5167 in Patients With Advanced Solid Tumors | recruiting | Phase 1 | 58 | DIGMBIOINDUSTRY | 1 | Aug 3, 2025 | clinicaltrials |
| NCT06305312 | Community Services Navigation to Advance Health Equity in Breast Cancer Screening(B-SINCERE) | recruiting | N/A | 1,450 | University of UtahOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06358625 | Identification of Risk Factors for Brain Recurrence in Patients With HER2-positive Localised Breast Cancer(CRANIUM) | recruiting | — | 120 | Center Eugene MarquisOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06462963 | OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)(SPRINT) | recruiting | N/A | 302 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Aug 1, 2025 | clinicaltrials |
| NCT05494502 | Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients | recruiting | N/A | 1,206 | Peking University First HospitalOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT07096180 | Clinical Observational Studies:Integrative TCM and Western Medicine for Breast Cancer | recruiting | — | 200 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT07020780 | 5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics | recruiting | N/A | 458 | IRCCS San RaffaeleOTHER | 1 | Jul 28, 2025 | clinicaltrials |
| NCT05035745 | Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START) | recruiting | Phase 1 / Phase 2 | 63 | National University Hospital, SingaporeOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT05181033 | Lenvatinib+Letrozole Versus Fulvestrant in Metastatic ER+/HER2- Breast Cancer, Post Progression on Al + CDK4/6 Inhibitor | recruiting | Phase 2 | 120 | National University Hospital, SingaporeOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT05491083 | Pembrolizumab and ADG106 in Advanced Solid Cancers and Triple Negative Breast Cancer(ComPACT) | recruiting | Phase 1 / Phase 2 | 51 | National University Hospital, SingaporeOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT05804578 | Using a Blood Test to Monitor Metastatic Breast Cancer Treatment(BEACON) | recruiting | — | 150 | Dr. Christopher MuellerOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT06174363 | Analgesic Efficacy of Maxigesic in Breast Cancer Surgery | recruiting | N/A | 84 | Yonsei UniversityOTHER | 1 | Jul 20, 2025 | clinicaltrials |
| NCT06666270 | Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors | recruiting | Phase 1 | 30 | Hangzhou SynRx Therapeutics Biomedical Technology Co., LtdINDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT07073755 | Real-World Study of Post-Resistance Treatment Strategies in Advanced Breast Cancer Following CDK4/6i, PIK3CA Inhibitors, or T-DXd | recruiting | — | 200 | Hunan Cancer HospitalOTHER | 1 | Jul 18, 2025 | clinicaltrials |
| NCT07071272 | Non-inferiority Study of Contrast-enhanced Digital Mammography (CEDM) vs Magnetic Resonance Imaging (MRI) in Terms of Diagnostic Accuracy in Patients Undergoing Preoperative Staging of Established Invasive Breast Cancer(CEDM-VR) | recruiting | N/A | 216 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT05658341 | Program of Physical Activity, Nutrition and Supportive to Improve the Quality of Life of Breast Cancer Survivors(ADA) | recruiting | N/A | 160 | Siel BleuOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07059104 | Implant-based Breast Reconstruction in Post-bariatric Women - a Registry-based National Study | recruiting | — | 20,000 | Vastra Gotaland RegionOTHER_GOV | 1 | Jul 16, 2025 | clinicaltrials |
| NCT07046689 | PET/CT for Trop2 ADC Response Evaluation Cancers | recruiting | — | 50 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT07065435 | RC48 Plus Bevacizumab or Pyrotinib in HER2-Positive Metastatic Breast Cancer After T-DXd Failure: A Phase II Study | recruiting | Phase 2 | 74 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT07066280 | Modulating the Skin Microbiome to Prevent Radiation Dermatitis in Breast Cancer | recruiting | Phase 3 | 326 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT07066917 | Mechanisms of Response and Resistance to Innovative Treatments in Patients With Locally Advanced or Metastatic Breast Cancer(PANDORA) | recruiting | — | 150 | Hellenic Cooperative Oncology GroupOTHER | 1 | Jul 15, 2025 | clinicaltrials |
| NCT06033287 | Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC. | recruiting | — | 300 | Hunan Cancer HospitalOTHER | 1 | Jul 11, 2025 | clinicaltrials |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study(ABILITY-1) | recruiting | Phase 1 / Phase 2 | 115 | Medicenna Therapeutics, Inc.INDUSTRY | 7 | Jul 9, 2025 | clinicaltrials |
| NCT05722795 | Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)(I-CONIC) | recruiting | N/A | 40 | Vastra Gotaland RegionOTHER_GOV | 1 | Jul 9, 2025 | clinicaltrials |
| NCT07057427 | Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer | recruiting | Phase 3 | 812 | Henan Cancer HospitalOTHER_GOV | 1 | Jul 9, 2025 | clinicaltrials |
| NCT05396612 | Role of the Immune Environment in Response to Therapy in Breast Cancer | recruiting | — | 300 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT06792721 | MEASUREMENT OF CIRCULATING MUTATION BURDEN(cRISK) | recruiting | — | 30 | Centre Francois BaclesseOTHER | 1 | Jul 8, 2025 | clinicaltrials |
| NCT04714463 | Effects of Expectations and Body Image in Breast Reconstruction | recruiting | — | 500 | Vastra Gotaland RegionOTHER_GOV | 1 | Jul 3, 2025 | clinicaltrials |
| NCT05222100 | Effect of Breast Implants om Mammography Screening | recruiting | — | 2,500 | Vastra Gotaland RegionOTHER_GOV | 1 | Jul 3, 2025 | clinicaltrials |
| NCT05233891 | Validation of Scales in Reconstructive Breast Surgery(ValPlast) | recruiting | — | 500 | Vastra Gotaland RegionOTHER_GOV | 1 | Jul 3, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Aug 20, 2025source: clinicaltrials